Skip to content
  • Home
  • Our research
  • Market
  • Plans
  • Partnering
  • About us
Menu
  • Home
  • Our research
  • Market
  • Plans
  • Partnering
  • About us

Delårsrapport kvartal 1, 2021

Contact us

Tore Duvold

Send e-mail
Twitter Linkedin Facebook Youtube

As part of Coegin Pharma AB’s hub & spoke “portfolio” business model, with clear benefits to investors, Coegin Pharma AB has established the Swedish portfolio company Follicum AB to further develop a highly promising dermacosmetic product line based on FOL005 to stimulate hair growth. Follicum AB will primarily be managed and financed separately from Coegin Pharma AB.

© All Rights Reserved